Octreotide long-acting repeatable in the treatment of neuroendocrine tumors: patient selection and perspectives

Yau H, Kinaan M, Quinn SL, Moraitis AG

Biologics: Targets and Therapy 2017, 11:115-122

Published Date: 6 December 2017